Andhra Pradesh: NMC Chairman Dr Abhijat Sheth recently mentioned that AI, digital health and advanced technology will strengthen medical education, streamline accreditation and reduce counselling delays. He announced that medical…
Vijayawada: A total of 1,454 public healthcare facilities across Andhra Pradesh have achieved accreditation under the National Quality Assurance Standards, Health Minister Satya Kumar Yadav informed on Wednesday. The institutions…
Bengaluru: Following the closure of 10 maternity hospitals run by the Greater Bengaluru Authority (GBA) for construction and renovation work, thousands of expectant mothers, particularly from low-income and migrant communities,…
Surat: A 28-year-old chemist in Surat allegedly began manufacturing the banned narcotic mephedrone (MD) after suffering heavy losses in foreign exchange (forex) trading, police investigations have revealed. The accused reportedly…
The application process is currently open, and eligible candidates must submit their forms offline within the prescribed deadline as mentioned in the official notification.
Nashik: The Maharashtra health department has reported a decline in the infant mortality rate among children under five years of age, due to free health check-ups and necessary treatments and…
Chandigarh: Observing that there was no medical negligence or deficiency in service during the spine treatment of a patient, the State Consumer Disputes Redressal Commission (SCDRC), Punjab, recently exonerated a…
New Delhi: Zydus Lifesciences Ltd has informed that Ampliman 2, France, a step-down wholly owned subsidiary of the company, has been dissolved without liquidation, effective January 9, 2026, according to…
Hyderabad: Dr. Reddy's Laboratories Ltd has received a Post-Application Action Letter (PAAL) from the United States Food and Drug Administration (USFDA) following the regulator's review of the company's response to…
New Delhi: India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 agonist brand Yurpeak gaining traction soon after launch, particularly across…